Diagnosing cancer earlier: what progress is being made?
作者信息
Richards M A, Hiom Sara, Hamilton Willie
机构信息
Cancer Research UK, London, UK.
Cancer Intelligence, GRAIL Europe, London, UK.
出版信息
Br J Cancer. 2023 Feb;128(3):441-442. doi: 10.1038/s41416-023-02171-8. Epub 2023 Feb 1.
Abstract
摘要
相似文献
1
Diagnosing cancer earlier: what progress is being made?更早地诊断癌症：正在取得哪些进展？
Br J Cancer. 2023 Feb;128(3):441-442. doi: 10.1038/s41416-023-02171-8. Epub 2023 Feb 1.
2
Diagnosing cancer earlier: reviewing the evidence for improving cancer survival.早期诊断癌症：审视改善癌症生存率的证据
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S1-5. doi: 10.1038/bjc.2015.23.
3
Approaches to diagnosing cancer earlier in general practice.在全科医疗中早期诊断癌症的方法。
Br J Gen Pract. 2021 Apr 29;71(706):196-197. doi: 10.3399/bjgp21X715613. Print 2021 May.
4
Raman spectroscopy and chemometrics: A potential universal method for diagnosing cancer.拉曼光谱学和化学计量学：一种潜在的癌症通用诊断方法。
Spectrochim Acta A Mol Biomol Spectrosc. 2019 Aug 5;219:463-487. doi: 10.1016/j.saa.2019.04.067. Epub 2019 Apr 25.
5
On diagnosing cancer histologically.关于通过组织学诊断癌症。
Lancet. 1956 May 19;270(6925):701-4.
6
[Organisation of diagnosing patients with unspecific cancer symptoms].[对有非特异性癌症症状患者的诊断组织]
Ugeskr Laeger. 2011 Jun 13;173(24):1718-21.
7
The cell smear method of diagnosing cancer.诊断癌症的细胞涂片法。
Am J Public Health Nations Health. 1948 Feb;38(2):202-5. doi: 10.2105/ajph.38.2.202.
8
Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer.癌症生物标志物：一种检测、诊断和治疗癌症的新兴手段。
Dis Markers. 2005;21(1):1-2. doi: 10.1155/2005/423023.
9
Is diagnosing cancer with a smartphone in our future?在我们的未来，能用智能手机诊断癌症吗？
Oncology (Williston Park). 2012 Sep;26(9):815.
10
Do diagnostic delays in cancer matter?癌症的诊断延迟有关系吗？
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S9-S12. doi: 10.1038/sj.bjc.6605384.
引用本文的文献
1
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.首发癌症症状特征：来自 2018 年英国国家癌症诊断审计的证据。
Br J Cancer. 2024 Feb;130(2):297-307. doi: 10.1038/s41416-023-02507-4. Epub 2023 Dec 6.
本文引用的文献
1
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.急诊入院后 30 天内诊断癌症（急诊就诊）的风险因素和预后意义：国际癌症基准合作组织（ICBP）基于人群的研究。
Lancet Oncol. 2022 May;23(5):587-600. doi: 10.1016/S1470-2045(22)00127-9. Epub 2022 Apr 6.
2
Trends in time to cancer diagnosis around the period of changing national guidance on referral of symptomatic patients: A serial cross-sectional study using UK electronic healthcare records from 2006-17.2006-2017 年期间，英国国家对症状性患者转诊指南进行调整前后，癌症诊断时间的变化趋势：一项使用英国电子医疗记录的连续时间序列研究。
Cancer Epidemiol. 2020 Dec;69:101805. doi: 10.1016/j.canep.2020.101805. Epub 2020 Sep 9.
3
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.新冠大流行期间 2 周候诊癌症转诊通道延迟对英国癌症生存率的影响：一项建模研究。
Lancet Oncol. 2020 Aug;21(8):1035-1044. doi: 10.1016/S1470-2045(20)30392-2. Epub 2020 Jul 20.
4
Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.解释国际癌症基准伙伴关系中11个辖区间癌症生存率差异：一项初级保健病例调查
BMJ Open. 2015 May 27;5(5):e007212. doi: 10.1136/bmjopen-2014-007212.
5
Diagnosing cancer earlier: reviewing the evidence for improving cancer survival.早期诊断癌症：审视改善癌症生存率的证据
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S1-5. doi: 10.1038/bjc.2015.23.
6
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.有症状癌症的诊断和治疗时间增加是否与较差的预后相关？系统评价。
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S92-107. doi: 10.1038/bjc.2015.48.
7
Emergency presentation of cancer and short-term mortality.癌症的紧急表现和短期死亡率。
Br J Cancer. 2013 Oct 15;109(8):2027-34. doi: 10.1038/bjc.2013.569. Epub 2013 Sep 17.
8
Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?澳大利亚、加拿大、丹麦、挪威、瑞典和英国（国际癌症基准合作组织）之间的癌症认知和信念差异：它们是否导致癌症生存率的差异？
Br J Cancer. 2013 Feb 5;108(2):292-300. doi: 10.1038/bjc.2012.542. Epub 2013 Jan 31.
9
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.2001-2004 年英格兰、挪威和瑞典的肺癌生存率的国家比较：随访早期就出现差异。
Thorax. 2010 May;65(5):436-41. doi: 10.1136/thx.2009.124222.
10
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?如果英国的癌症存活率与欧洲相同：有多少死亡是可以避免的？
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S115-24. doi: 10.1038/sj.bjc.6605401.
Zotero 插件